WuXi Biologics (Cayman) Inc (WXIBF)
1.695
0.00 (0.00%)
USD |
OTCM |
May 24, 16:00
WuXi Biologics Total Liabilities (Quarterly): 1.772B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.772B |
| June 30, 2023 | 1.806B |
| June 30, 2023 | 1.806B |
| December 31, 2022 | 1.935B |
| June 30, 2022 | 1.789B |
| June 30, 2022 | 1.789B |
| December 31, 2021 | 1.777B |
| June 30, 2021 | 1.546B |
| June 30, 2021 | 1.546B |
| December 31, 2020 | 1.234B |
| June 30, 2020 | 979.44M |
| Date | Value |
|---|---|
| June 30, 2020 | 979.44M |
| December 31, 2019 | 672.62M |
| June 30, 2019 | 242.15M |
| June 30, 2019 | 242.15M |
| December 31, 2018 | 203.36M |
| June 30, 2018 | 159.80M |
| June 30, 2018 | 159.80M |
| December 31, 2017 | 126.30M |
| June 30, 2017 | 266.65M |
| June 30, 2017 | 266.65M |
| December 31, 2016 | 246.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
242.15M
Minimum
Jun 2019
1.935B
Maximum
Dec 2022
1.341B
Average
1.546B
Median
Jun 2021
Total Liabilities (Quarterly) Benchmarks
| Wuxi AppTec Co Ltd | 2.655B |
| Sinovac Biotech Ltd | 1.635B |
| CASI Pharmaceuticals Inc | 42.54M |
| Zai Lab Ltd | 226.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.981B |
| Shareholders Equity (Quarterly) | 5.690B |
| Debt to Equity Ratio | 0.0532 |
| Current Ratio | 2.776 |
| Net Debt Paydown Yield | 0.27% |